Literature DB >> 26279745

Pancreatic and duodenal homeobox gene 1 (Pdx1) down-regulates hepatic transcription factor 1 alpha (HNF1α) expression during reprogramming of human hepatic cells into insulin-producing cells.

William Donelan1, Shiwu Li1, Hai Wang1, Shun Lu1, Chao Xie1, Dongqi Tang1, Lung-Ji Chang2, Li-Jun Yang1.   

Abstract

Ectopic expression of Pdx1 triggers rapid hepatocyte dedifferentiation by down-regulating liver-enriched transcription factors and liver-specific functional genes such as hepatic nuclear factor-1α (HNF1α), albumin, and AAT. However, the links between Pdx1 over-expression and hepatic gene down-regulation are incompletely understood. HNF1α and HNF4α are important transcription factors that establish and maintain the hepatocyte phenotype. The human HNF4α gene contains two promoters (P1 and P2) that drive expression of P1-(HNF4α 1-6) or P2-(HNF4α 7-9)-derived isoforms, which are used in different tissues and at different times during development. We hypothesized that the relative expression of HNF1α and HNF4α following ectopic Pdx1 expression may promote hepatic cell dedifferentiation and transdifferentiation toward pancreatic beta-cells. We produced lentiviruses expressing Pdx1, Pdx1-VP16, and Ngn3, along with dual-color reporter genes to indicate hepatic and pancreatic beta-cell phenotype changes. Using these PTF alone or in combinations, we demonstrated that Pdx1 not only activates specific beta-cell genes but down-regulates HNF1α. Pdx1-mediated reduction of HNF1α is accompanied by altered expression of its major activator, HNF4α isoforms, down-regulating hepatic genes ALB and AAT. Pdx1 up-regulates HNF4α via the P2 promoter. These P2-driven isoforms compete with P1-driven isoforms to suppress target gene transcription. In Huh7 cells, the AF-1 activation domain is more important for transactivation, whereas in INS1 cells, the F inhibitory domain is more important. The loss and gain of functional activity strongly suggests that Pdx1 plays a central role in reprogramming hepatocytes into beta-cells by suppressing the hepatic phenotype.

Entities:  

Keywords:  HNF1α; HNF4α; Huh7 cells; Ngn3; Pdx1; Pdx1-VP16; human hepatic cells; insulin-producing cells (IPCs); reprogramming; transdifferentiation

Year:  2015        PMID: 26279745      PMCID: PMC4532734     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  60 in total

Review 1.  Embryonic development of the liver.

Authors:  Roong Zhao; Stephen A Duncan
Journal:  Hepatology       Date:  2005-05       Impact factor: 17.425

2.  Purified hepatocyte nuclear factor 1 interacts with a family of hepatocyte-specific promoters.

Authors:  G Courtois; S Baumhueter; G R Crabtree
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

3.  A glycosylated liver-specific transcription factor stimulates transcription of the albumin gene.

Authors:  S Lichtsteiner; U Schibler
Journal:  Cell       Date:  1989-06-30       Impact factor: 41.582

4.  Proteins binding to the liver-specific pyruvate kinase gene promoter. A unique combination of known factors.

Authors:  S Vaulont; N Puzenat; F Levrat; M Cognet; A Kahn; M Raymondjean
Journal:  J Mol Biol       Date:  1989-09-20       Impact factor: 5.469

5.  High glucose is necessary for complete maturation of Pdx1-VP16-expressing hepatic cells into functional insulin-producing cells.

Authors:  Li-Zhen Cao; Dong-Qi Tang; Marko E Horb; Shi-Wu Li; Li-Jun Yang
Journal:  Diabetes       Date:  2004-12       Impact factor: 9.461

6.  Adult rat liver cells transdifferentiated with lentiviral IPF1 vectors reverse diabetes in mice: an ex vivo gene therapy approach.

Authors:  A Fodor; C Harel; L Fodor; M Armoni; P Salmon; D Trono; E Karnieli
Journal:  Diabetologia       Date:  2006-11-28       Impact factor: 10.122

7.  Novel P2 promoter-derived HNF4alpha isoforms with different N-terminus generated by alternate exon insertion.

Authors:  Jianmin Huang; Lynne L Levitsky; David B Rhoads
Journal:  Exp Cell Res       Date:  2009-04-15       Impact factor: 3.905

8.  Reversal of streptozotocin-induced diabetes in mice by cellular transduction with recombinant pancreatic transcription factor pancreatic duodenal homeobox-1: a novel protein transduction domain-based therapy.

Authors:  Vijay Koya; Shun Lu; Yu-Ping Sun; Daniel L Purich; Mark A Atkinson; Shi-Wu Li; Li-Jun Yang
Journal:  Diabetes       Date:  2007-12-17       Impact factor: 9.461

9.  A bipotential precursor population for pancreas and liver within the embryonic endoderm.

Authors:  G Deutsch; J Jung; M Zheng; J Lóra; K S Zaret
Journal:  Development       Date:  2001-03       Impact factor: 6.868

10.  Stem cell approaches for diabetes: towards beta cell replacement.

Authors:  Gordon C Weir; Claudia Cavelti-Weder; Susan Bonner-Weir
Journal:  Genome Med       Date:  2011-09-27       Impact factor: 11.117

View more
  7 in total

1.  PAX4 promotes PDX1-induced differentiation of mesenchymal stem cells into insulin-secreting cells.

Authors:  Lifa Xu; Congjing Xu; Shuping Zhou; Xueke Liu; Jian Wang; Xinkuang Liu; Suping Qian; Yingru Xin; Yi Gao; Yongqiang Zhu; Xiaolong Tang
Journal:  Am J Transl Res       Date:  2017-03-15       Impact factor: 4.060

Review 2.  Regenerative medicine and cell-based approaches to restore pancreatic function.

Authors:  Cara Ellis; Adam Ramzy; Timothy J Kieffer
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-08-16       Impact factor: 46.802

Review 3.  Limitations and challenges of direct cell reprogramming in vitro and in vivo.

Authors:  Yi-Xuan Zhang; Si-Lin Chen; Yu-Mei Li; Yun-Wen Zheng
Journal:  Histol Histopathol       Date:  2022-04-13       Impact factor: 2.130

Review 4.  Direct Lineage Reprogramming: Harnessing Cell Plasticity between Liver and Pancreas.

Authors:  Silvia Ruzittu; David Willnow; Francesca M Spagnoli
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-07-01       Impact factor: 9.708

5.  Combined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model.

Authors:  Adel Galal El-Shemi; Ahmad Mohammed Ashshi; Youjin Na; Yan Li; Mohammed Basalamah; Faisal Ahmad Al-Allaf; Eonju Oh; Bo-Kyeong Jung; Chae-Ok Yun
Journal:  J Exp Clin Cancer Res       Date:  2016-05-06

6.  Efficacy of combining ING4 and TRAIL genes in cancer-targeting gene virotherapy strategy: first evidence in preclinical hepatocellular carcinoma.

Authors:  A Galal El-Shemi; A Mohammed Ashshi; E Oh; B-K Jung; M Basalamah; A Alsaegh; C-O Yun
Journal:  Gene Ther       Date:  2017-09-19       Impact factor: 5.250

7.  BMSCs and miR-124a ameliorated diabetic nephropathy via inhibiting notch signalling pathway.

Authors:  Jiping Sun; Fei Zhao; Wenjing Zhang; Jia Lv; Jing Lv; Aiping Yin
Journal:  J Cell Mol Med       Date:  2018-07-19       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.